TipRanks
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market
TNYA
Tenaya Therapeutics
RESEARCH TOOLSreports
Want to see TNYA full AI Analyst Report?

Tenaya Therapeutics (TNYA) Ratios

3,473 Followers

Tenaya Therapeutics Ratios

TNYA's free cash flow for Q2 2026 was $1.00. For the 2026 fiscal year, TNYA's free cash flow was decreased by $ and operating cash flow was $-39.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.52 6.84 4.22 4.91 7.99
Quick Ratio
 4.52 6.84 4.22 4.91 7.99
Cash Ratio
 4.11 6.51 0.27 2.01 3.93
Solvency Ratio
 -3.98 -3.47 -3.79 -3.71 -3.23
Operating Cash Flow Ratio
 -3.76 -4.42 -5.67 -4.49 -4.31
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -32.58 0.00 0.00
Net Current Asset Value
$ 61.88M$ 81.93M$ 40.29M$ 80.49M$ 158.19M
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.07 0.11 0.07 0.05
Debt-to-Equity Ratio
 0.06 0.09 0.15 0.09 0.06
Debt-to-Capital Ratio
 0.05 0.08 0.13 0.08 0.06
Long-Term Debt-to-Capital Ratio
 0.00 0.06 0.00 0.00 0.00
Financial Leverage Ratio
 1.35 1.19 1.29 1.22 1.15
Debt Service Coverage Ratio
 0.00 0.00 -36.96 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.07 0.02 0.00 0.00
Interest Debt Per Share
 0.02 0.07 0.16 0.17 0.34
Net Debt to EBITDA
 0.77 1.09 -0.09 0.29 0.70
Profitability Margins
Gross Profit Margin
263.67%0.00%0.00%0.00%0.00%
EBIT Margin
-7723.97%0.00%0.00%0.00%0.00%
EBITDA Margin
-7188.09%0.00%0.00%0.00%0.00%
Operating Profit Margin
-7929.89%0.00%0.00%0.00%0.00%
Pretax Profit Margin
-7723.97%0.00%0.00%0.00%0.00%
Net Profit Margin
-7723.97%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
-7723.97%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
97.40%97.07%95.84%94.58%98.44%
Return on Assets (ROA)
-110.24%-61.66%-92.65%-72.77%-44.33%
Return on Equity (ROE)
-108.05%-73.50%-119.68%-89.00%-50.81%
Return on Capital Employed (ROCE)
-142.06%-70.98%-111.53%-88.77%-49.32%
Return on Invested Capital (ROIC)
-136.78%-69.39%-108.62%-86.25%-48.56%
Return on Tangible Assets
-110.24%-61.66%-92.65%-72.77%-44.33%
Earnings Yield
-84.02%-83.24%-91.62%-51.90%-137.26%
Efficiency Ratios
Receivables Turnover
 3.60 0.00 0.00 0.00 0.00
Payables Turnover
 -0.75 2.36 1.64 1.54 0.91
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.24 0.00 0.00 0.00 0.00
Asset Turnover
 0.01 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.02 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 586.21 -154.94 -222.50 -236.55 -401.24
Days of Sales Outstanding
 101.43 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 -484.77 154.94 222.50 236.55 401.24
Operating Cycle
 101.43 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.33 -0.45 -1.07 -1.38 -2.33
Free Cash Flow Per Share
 -0.33 -0.45 -1.08 -1.40 -2.79
CapEx Per Share
 <0.01 <0.01 0.01 0.02 0.46
Free Cash Flow to Operating Cash Flow
 1.00 1.01 1.01 1.01 1.20
Dividend Paid and CapEx Coverage Ratio
 -261.16 -110.46 -88.29 -82.38 -5.06
Capital Expenditure Coverage Ratio
 -261.16 -110.46 -88.29 -82.38 -5.06
Operating Cash Flow Coverage Ratio
 -18.12 -6.30 -6.65 -8.22 -6.92
Operating Cash Flow to Sales Ratio
 -53.60 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-58.68%-63.29%-75.46%-43.21%-138.80%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.06 -1.21 -1.09 -1.93 -0.73
Price-to-Sales (P/S) Ratio
 91.69 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 1.77 0.88 1.31 1.71 0.37
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.70 -1.58 -1.33 -2.31 -0.72
Price-to-Operating Cash Flow Ratio
 -1.72 -1.59 -1.34 -2.34 -0.86
Price-to-Earnings Growth (PEG) Ratio
 -0.02 0.02 0.05 0.05 -0.01
Price-to-Fair Value
 1.77 0.88 1.31 1.71 0.37
Enterprise Value Multiple
 -0.50 -0.23 -1.27 -1.78 -0.09
Enterprise Value
 48.27M 19.12M 130.58M 205.81M 9.92M
EV to EBITDA
 -0.50 -0.23 -1.27 -1.78 -0.09
EV to Sales
 36.16 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -0.67 -0.28 -1.43 -1.99 -0.08
EV to Operating Cash Flow
 -0.67 -0.28 -1.44 -2.02 -0.10
Tangible Book Value Per Share
 0.32 0.81 1.09 1.89 5.43
Shareholders’ Equity Per Share
 0.32 0.81 1.09 1.89 5.43
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 0.00 0.00 0.00 0.00
Net Income Per Share
 -0.47 -0.59 -1.31 -1.68 -2.76
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
 46.15 0.00 0.00 0.00 0.00
SG&A to Revenue
 16.78 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 8.82 0.00 0.00 0.00 0.00
Income Quality
 0.58 0.75 0.81 0.82 0.84
Currency in USD